What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Cancer
Karine Breckpot spends much of her time researching Immunology, Cytotoxic T cell, Antigen, Immune system and Dendritic cell.
Her studies in Immunology integrate themes in fields like Cancer cell and Clinical trial.
Karine Breckpot has included themes like Molecular biology and Cancer immunotherapy in her Antigen study.
Karine Breckpot combines subjects such as Cancer research, Genetic enhancement, Tumor antigen and In vivo with her study of Cancer immunotherapy.
All of her Immune system and Immunotherapy and Toll-like receptor investigations are sub-components of the entire Immune system study.
T cell and Conserved sequence is closely connected to Cell biology in her research, which is encompassed under the umbrella topic of Dendritic cell.
Her most cited work include:
- Consensus guidelines for the detection of immunogenic cell death (449 citations)
- Combinatorial Strategies for the Induction of Immunogenic Cell Death (220 citations)
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death (197 citations)
What are the main themes of her work throughout her whole career to date?
Karine Breckpot focuses on Cancer research, Immunology, Immune system, Immunotherapy and Dendritic cell.
Her Cancer research study combines topics from a wide range of disciplines, such as Tumor microenvironment, Cancer, Cancer immunotherapy, PD-L1 and In vivo.
Her studies examine the connections between Cancer immunotherapy and genetics, as well as such issues in Viral vector, with regards to Genetic enhancement.
Her research integrates issues of Ex vivo and Cell therapy in her study of Immunology.
Her Immune system research is multidisciplinary, incorporating perspectives in Cancer cell, Myeloid-derived Suppressor Cell and Antigen.
As a part of the same scientific study, Karine Breckpot usually deals with the Dendritic cell, concentrating on Cell biology and frequently concerns with CD40 and Cell.
She most often published in these fields:
- Cancer research (44.44%)
- Immunology (33.89%)
- Immune system (32.22%)
What were the highlights of her more recent work (between 2017-2021)?
- Cancer research (44.44%)
- Immune system (32.22%)
- Cancer (15.00%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include Cancer research, Immune system, Cancer, Immunotherapy and PD-L1.
Her studies deal with areas such as Immune checkpoint, Tumor microenvironment, T cell, Immunogenic cell death and Single-domain antibody as well as Cancer research.
The study incorporates disciplines such as Peripheral tolerance, Dendritic cell, Immune tolerance and Antigen in addition to Tumor microenvironment.
Karine Breckpot works mostly in the field of Immune system, limiting it down to topics relating to Monoclonal antibody and, in certain cases, Molecular biology and Breast cancer.
The Cancer cell research Karine Breckpot does as part of her general Cancer study is frequently linked to other disciplines of science, such as Neuropilin 1, therefore creating a link between diverse domains of science.
In her study, which falls under the umbrella issue of Immunotherapy, CD8 and Viral vector is strongly linked to Cytotoxic T cell.
Between 2017 and 2021, her most popular works were:
- Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression (59 citations)
- Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy. (43 citations)
- Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety (31 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
Karine Breckpot mainly focuses on Cancer research, Immunotherapy, Immune system, T cell and Dendritic cell.
The concepts of her Cancer research study are interwoven with issues in Tumor microenvironment, Metastasis, Monoclonal antibody and Immune checkpoint.
Karine Breckpot works mostly in the field of Immunotherapy, limiting it down to topics relating to Cancer cell and, in certain cases, Myelopoiesis, as a part of the same area of interest.
Her work carried out in the field of Immune system brings together such families of science as Epigenetics and DNA Methyltransferase Inhibitor.
Her T cell study incorporates themes from Cell, Cytotoxic T cell and Cancer immunotherapy.
Her Dendritic cell research is multidisciplinary, relying on both Immunogenic cell death, Plasma cell, CD8 and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
